113 related articles for article (PubMed ID: 37690597)
1. DDD-028: A potent, neuroprotective, non-opioid compound for the treatment of diabetic neuropathy.
Micheli L; Rajamoni J; Di Cesare Mannelli L; Rajagopalan P; Ghelardini C; Rajagopalan R
Bioorg Med Chem Lett; 2023 Oct; 95():129472. PubMed ID: 37690597
[TBL] [Abstract][Full Text] [Related]
2. Broad-spectrum neuroprotection exerted by DDD-028 in a mouse model of chemotherapy-induced neuropathy.
Lucarini E; Micheli L; Rajagopalan R; Ciampi C; Branca JJV; Pacini A; Leandri M; Rajagopalan P; Ghelardini C; Di Cesare Mannelli L
Pain; 2023 Nov; 164(11):2581-2595. PubMed ID: 37556385
[TBL] [Abstract][Full Text] [Related]
3. Antineuropathic effect of 7-hydroxy-3,4-dihydrocadalin in streptozotocin-induced diabetic rodents.
Rocha-González HI; Ramírez-Aguilar M; Granados-Soto V; Reyes-García JG; Torres-López JE; Huerta-Cruz JC; Navarrete A
BMC Complement Altern Med; 2014 Apr; 14():129. PubMed ID: 24708659
[TBL] [Abstract][Full Text] [Related]
4. AS1069562, the (+)-isomer of indeloxazine, but not duloxetine has a curative-like analgesic effect in a rat model of streptozotocin-induced diabetic neuropathy.
Murai N; Aoki T; Tamura S; Yamamoto H; Hamakawa N; Matsuoka N
Neuropharmacology; 2014 Apr; 79():10-6. PubMed ID: 24211301
[TBL] [Abstract][Full Text] [Related]
5. Phloretin either alone or in combination with duloxetine alleviates the STZ-induced diabetic neuropathy in rats.
Balaha M; Kandeel S; Kabel A
Biomed Pharmacother; 2018 May; 101():821-832. PubMed ID: 29635891
[TBL] [Abstract][Full Text] [Related]
6. DDD-028: a potent potential non-opioid, non-cannabinoid analgesic for neuropathic and inflammatory pain.
Rajagopalan P; Tracey H; Chen Z; Bandyopadhyaya A; Veeraraghavan S; Rajagopalan DR; Salvemini D; McPhee I; Viswanadha S; Rajagopalan R
Bioorg Med Chem Lett; 2014 Jul; 24(14):3088-91. PubMed ID: 24863744
[TBL] [Abstract][Full Text] [Related]
7. Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin.
Ma J; Yu H; Liu J; Chen Y; Wang Q; Xiang L
Eur J Pharmacol; 2015 Oct; 764():599-606. PubMed ID: 26054810
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Natural Compounds for Therapeutic Potential in Streptozotocin-induced Diabetic Neuroinflammation and Neuropathic Pain.
Faheem M; Khan AU; Shah FA; Li S
Front Pharmacol; 2022; 13():1019033. PubMed ID: 36278164
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
Carlos F; Espejel L; Novick D; López R; Flores D
Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Quercetin Obtained from
Dureshahwar K; Mubashir M; Une HD
Pharmacognosy Res; 2017; 9(3):287-293. PubMed ID: 28827972
[TBL] [Abstract][Full Text] [Related]
11. Ameliorative potential of rutin in combination with nimesulide in STZ model of diabetic neuropathy: targeting Nrf2/HO-1/NF-kB and COX signalling pathway.
Mittal R; Kumar A; Singh DP; Bishnoi M; Nag TC
Inflammopharmacology; 2018 Jun; 26(3):755-768. PubMed ID: 29094308
[TBL] [Abstract][Full Text] [Related]
12. Topiramate affords neuroprotection in diabetic neuropathy model via downregulating spinal GFAP/inflammatory burden and improving neurofilament production.
Attia MA; Soliman N; Eladl MA; Bilasy SE; El-Abaseri TB; Ali HS; Abbas F; Ibrahim D; Osman NMS; Hashish AA; Alshahrani A; Mohamed AS; Zaitone SA
Toxicol Mech Methods; 2023 Sep; 33(7):563-577. PubMed ID: 36978280
[TBL] [Abstract][Full Text] [Related]
13. Ameliorative Effect of Berberine on Neonatally Induced Type 2 Diabetic Neuropathy via Modulation of BDNF, IGF-1, PPAR-γ, and AMPK Expressions.
Zhou G; Yan M; Guo G; Tong N
Dose Response; 2019; 17(3):1559325819862449. PubMed ID: 31360147
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of extracellular signal-regulated kinase 1/2 in subepidermal nerve fibers mediates hyperalgesia following diabetic peripheral neuropathy.
Liu CH; Lan CT; Chen LY; Liao WC; Ko MH; Tseng TJ
Neurotoxicology; 2019 Mar; 71():60-74. PubMed ID: 30583000
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model.
Miyazaki R; Yamamoto T
Anesth Analg; 2012 Jul; 115(1):182-8. PubMed ID: 22415534
[TBL] [Abstract][Full Text] [Related]
16. A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
O'Connor AB; Noyes K; Holloway RG
Pharmacoeconomics; 2008; 26(12):1045-64. PubMed ID: 19014205
[TBL] [Abstract][Full Text] [Related]
17. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy.
Bachewal P; Gundu C; Yerra VG; Kalvala AK; Areti A; Kumar A
Biofactors; 2018 Mar; 44(2):109-122. PubMed ID: 29193444
[TBL] [Abstract][Full Text] [Related]
18. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy.
Kiguchi S; Imamura T; Ichikawa K; Kojima M
Clin Exp Pharmacol Physiol; 2004; 31(1-2):57-64. PubMed ID: 14756685
[TBL] [Abstract][Full Text] [Related]
19. Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms.
Meyer L; Patte-Mensah C; Taleb O; Mensah-Nyagan AG
PLoS One; 2013; 8(11):e80915. PubMed ID: 24260511
[TBL] [Abstract][Full Text] [Related]
20. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
